U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975514) titled 'Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder' on May 09.
Brief Summary: The main purpose of this study is to assess efficacy of YZJ-1139 for 28 days in adult subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.
Study Start Date: March 25
Study Type: INTERVENTIONAL
Condition:
Insomnia Disorder
Intervention:
DRUG: YZJ-1139
YZJ-1139 20mg tablets, once daily in the evening
DRUG: Zolpidem
Zolpidem 10mg tablets, once daily in the evening
Recruitment Status: RECRUITING
Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Disclaimer: Curated by HT ...